Works matching IS 0009-9236 AND VI 116 AND IP 4 AND DT 2024

Results: 32

In This Issue.

Published in:: Clinical Pharmacology & Therapeutics, 2024, v. 116, n. 4, p. 883, doi. 10.1002/cpt.3412
Publication type:: Article

Highlighted Articles.

Published in:: Clinical Pharmacology & Therapeutics, 2024, v. 116, n. 4, p. 890, doi. 10.1002/cpt.3411
Publication type:: Article

PharmVar GeneFocus: CYP4F2.

Published in:

Clinical Pharmacology & Therapeutics, 2024, v. 116, n. 4, p. 963, doi. 10.1002/cpt.3405

By:

Zubiaur, Pablo;
Rodríguez‐Antona, Cristina;
Boone, Erin C.;
Daly, Ann K.;
Tsermpini, Evangelia Eirini;
Khasawneh, Lubna Q.;
Sangkuhl, Katrin;
Duconge, Jorge;
Botton, Mariana R.;
Savieo, Jessica;
Nofziger, Charity;
Whirl‐Carrillo, Michelle;
Klein, Teri E.;
Gaedigk, Andrea

Publication type:

Article

Is Pharmacogenetic Testing a Vital Tool for Enhancing Therapeutic Management of Patients Worldwide?

Published in:

Clinical Pharmacology & Therapeutics, 2024, v. 116, n. 4, p. 885, doi. 10.1002/cpt.3404

By:

Giacomini, Kathleen M.;
van der Graaf, Piet H.

Publication type:

Article

Pharmacogenomic Prescribing Guidelines: Are They Always Useful?

Published in:

Clinical Pharmacology & Therapeutics, 2024, v. 116, n. 4, p. 899, doi. 10.1002/cpt.3403

By:

Ingelman‐Sundberg, Magnus

Publication type:

Article

Development of a Multifaceted Program for Pharmacogenetics Adoption at an Academic Medical Center: Practical Considerations and Lessons Learned.

Published in:

Clinical Pharmacology & Therapeutics, 2024, v. 116, n. 4, p. 914, doi. 10.1002/cpt.3402

By:

Shugg, Tyler;
Tillman, Emma M.;
Breman, Amy M.;
Hodge, Jennelle C.;
McDonald, Christine A.;
Ly, Reynold C.;
Rowe, Elizabeth J.;
Osei, Wilberforce;
Smith, Tayler B.;
Schwartz, Peter H.;
Callaghan, John T.;
Pratt, Victoria M.;
Lynch, Sheryl;
Eadon, Michael T.;
Skaar, Todd C.

Publication type:

Article

The Value of Clinical Pharmacogenomic Guidelines That Recommend Standard of Care Over Genotype‐Based Prescribing.

Published in:

Clinical Pharmacology & Therapeutics, 2024, v. 116, n. 4, p. 897, doi. 10.1002/cpt.3401

By:

Donnelly, Roseann S.;
Whirl‐Carrillo, Michelle;
Klein, Teri E.;
Caudle, Kelly E.

Publication type:

Article

ASCPT News.

Published in:: Clinical Pharmacology & Therapeutics, 2024, v. 116, n. 4, p. 892, doi. 10.1002/cpt.3400
Publication type:: Article

Correction to "Effect of CYP4F2, VKORC1, and CYP2C9 in Influencing Coumarin Dose: A Single‐Patient Data Meta‐Analysis in More Than 15,000 Individuals".

Published in:: Clinical Pharmacology & Therapeutics, 2024, v. 116, n. 4, p. 1142, doi. 10.1002/cpt.3395
Publication type:: Article

PharmVar GeneFocus: CYP2A6.

Published in:

Clinical Pharmacology & Therapeutics, 2024, v. 116, n. 4, p. 948, doi. 10.1002/cpt.3387

By:

Langlois, Alec W.R.;
Chenoweth, Meghan J.;
Twesigomwe, David;
Scantamburlo, Giada;
Whirl‐Carrillo, Michelle;
Sangkuhl, Katrin;
Klein, Teri E.;
Nofziger, Charity;
Tyndale, Rachel F.;
Gaedigk, Andrea

Publication type:

Article

PBPK Modeling of Entrectinib and Its Active Metabolite to Derive Dose Adjustments in Pediatric Populations Co‐Administered with CYP3A4 Inhibitors.

Published in:

Clinical Pharmacology & Therapeutics, 2024, v. 116, n. 4, p. 1130, doi. 10.1002/cpt.3386

By:

Umehara, Kenichi;
Parrott, Neil;
Schindler, Emilie;
Legras, Valentin;
Meneses‐Lorente, Georgina

Publication type:

Article

Phenoconversion Due to Drug–Drug Interactions in CYP2C19 Genotyped Healthy Volunteers.

Published in:

Clinical Pharmacology & Therapeutics, 2024, v. 116, n. 4, p. 1121, doi. 10.1002/cpt.3378

By:

Abouir, Kenza;
Exquis, Nadia;
Gloor, Yvonne;
Daali, Youssef;
Samer, Caroline Flora

Publication type:

Article

Predicting Survival in Patients with Advanced NSCLC Treated with Atezolizumab Using Pre‐ and on‐Treatment Prognostic Biomarkers.

Published in:

Clinical Pharmacology & Therapeutics, 2024, v. 116, n. 4, p. 1110, doi. 10.1002/cpt.3371

By:

Benzekry, Sébastien;
Karlsen, Mélanie;
Bigarré, Célestin;
Kaoutari, Abdessamad El;
Gomes, Bruno;
Stern, Martin;
Neubert, Ales;
Bruno, Rene;
Mercier, François;
Vatakuti, Suresh;
Curle, Peter;
Jamois, Candice

Publication type:

Article

Integrated Population Exposure–Response of Dolutegravir in HIV‐1 Supports Bridging of Clinical Response Influenced by Relevant Intrinsic and Extrinsic Patient Characteristics.

Published in:

Clinical Pharmacology & Therapeutics, 2024, v. 116, n. 4, p. 1100, doi. 10.1002/cpt.3370

By:

Chandasana, Hardik;
Bush, Mark;
Vavro, Cindy;
Huang, Jenny;
Ait‐Khaled, Mounir;
Wynne, Brian;
Min, Sherene;
Mehta, Rashmi

Publication type:

Article

Age‐Dependent Abundance of CYP450 Enzymes Involved in Metronidazole Metabolism: Application to Pediatric PBPK Modeling.

Published in:

Clinical Pharmacology & Therapeutics, 2024, v. 116, n. 4, p. 1090, doi. 10.1002/cpt.3354

By:

Parvez, Md Masud;
Thakur, Aarzoo;
Mehrotra, Aanchal;
Stancil, Stephani;
Pearce, Robin E.;
Basit, Abdul;
Leeder, J. Steven;
Prasad, Bhagwat

Publication type:

Article

Clinical Pharmacogenetics Implementation Consortium Guideline (CPIC) for CYP2D6, ADRB1, ADRB2, ADRA2C, GRK4, and GRK5 Genotypes and Beta‐Blocker Therapy.

Published in:

Clinical Pharmacology & Therapeutics, 2024, v. 116, n. 4, p. 939, doi. 10.1002/cpt.3351

By:

Duarte, Julio D.;
Thomas, Cameron D.;
Lee, Craig R.;
Huddart, Rachel;
Agundez, Jose A. G.;
Baye, Jordan F.;
Gaedigk, Andrea;
Klein, Teri E.;
Lanfear, David E.;
Monte, Andrew A.;
Nagy, Mohamed;
Schwab, Matthias;
Stein, C. Michael;
Uppugunduri, Chakradhara Rao S.;
van Schaik, Ron H. N.;
Donnelly, Roseann S.;
Caudle, Kelly E.;
Luzum, Jasmine A.

Publication type:

Article

Role of Clinical Pharmacology in Diversity and Inclusion in Global Drug Development: Current Practices and Industry Perspectives: White Paper.

Published in:

Clinical Pharmacology & Therapeutics, 2024, v. 116, n. 4, p. 902, doi. 10.1002/cpt.3350

By:

Sawant‐Basak, Aarti;
Urva, Shweta;
Mukker, Jatinder Kaur;
Haertter, Sebastian;
Mariano, Dean;
Parasrampuria, Dolly A.;
Goteti, Kosalaram;
Singh, Ravi Shankar Prasad;
Chiney, Manoj;
Liao, Michael Z.;
Chang, Sandy S.;
Mehta, Rashmi

Publication type:

Article

Assessing the Performance of In silico Tools and Molecular Dynamics Simulations for Predicting Pharmacogenetic Variant Impact.

Published in:

Clinical Pharmacology & Therapeutics, 2024, v. 116, n. 4, p. 1082, doi. 10.1002/cpt.3348

By:

AlSaeed, Maryam Jamal;
Ramdhan, Peter;
Malave, Jean Gabriel;
Eljilany, Islam;
Langaee, Taimour;
McDonough, Caitrin W.;
Seabra, Gustavo;
Li, Chenglong;
Cavallari, Larisa H.

Publication type:

Article

Corrigendum: "Comparative Effectiveness of Bimekizumab in Psoriatic Arthritis: A Model‐Based Meta‐Analysis of American College of Rheumatology Response Criteria".

Published in:: Clinical Pharmacology & Therapeutics, 2024, v. 116, n. 4, p. 1141, doi. 10.1002/cpt.3346
Publication type:: Article

Model‐informed Evidence for Clinical Non‐inferiority of Every‐2‐Weeks Versus Standard Weekly Dosing Schedule of Cetuximab in Metastatic Colorectal Cancer.

Published in:

Clinical Pharmacology & Therapeutics, 2024, v. 116, n. 4, p. 1071, doi. 10.1002/cpt.3345

By:

Milenković‐Grišić, Ana‐Marija;
Hayes, Siobhán;
Farrell, Colm;
Kuroki, Yoshihiro;
Bertolino, Mauro;
Venkatakrishnan, Karthik;
Girard, Pascal

Publication type:

Article

Pharmacogenetics of Efavirenz Exposure in Cervicovaginal Fluid during Pregnancy and Postpartum.

Published in:

Clinical Pharmacology & Therapeutics, 2024, v. 116, n. 4, p. 1062, doi. 10.1002/cpt.3343

By:

Eniayewu, Oluwasegun;
Azuka, Uche;
Ogah, Jonah;
Adejuyigbe, Ebunoluwa;
Bolaji, Oluseye;
Olagunju, Adeniyi

Publication type:

Article

Pharmacokinetics, Pharmacodynamics, and Safety of Vadadustat in Healthy Volunteers and Patients with Chronic Kidney Disease.

Published in:

Clinical Pharmacology & Therapeutics, 2024, v. 116, n. 4, p. 1052, doi. 10.1002/cpt.3342

By:

Navarro‐Gonzales, Pamela;
Ganz, Tomas;
Pergola, Pablo E.;
Zuk, Anna;
Dykstra, Kevin

Publication type:

Article

Clinical Pharmacology of Glucagon.

Published in:

Clinical Pharmacology & Therapeutics, 2024, v. 116, n. 4, p. 976, doi. 10.1002/cpt.3340

By:

Kronfol, Mohamad M.;
Chow, Edwin C.;
Lau, S. W. Johnny;
Nounou, Mohamed I.;
Vaidyanathan, Jayabharathi;
Seo, Shirley K.

Publication type:

Article

Multicenter Pharmacokinetic and Pharmacodynamic Study of Pembrolizumab for Non‐small‐Cell Lung Cancer in Patients Aged 75 Years and Older.

Published in:

Clinical Pharmacology & Therapeutics, 2024, v. 116, n. 4, p. 1042, doi. 10.1002/cpt.3339

By:

Yagishita, Shigehiro;
Yamanaka, Yuta;
Kurata, Takayasu;
Watanabe, Kageaki;
Hosomi, Yukio;
Horinouchi, Hidehito;
Ohe, Yuichiro;
Nakahara, Yoshiro;
Naoki, Katsuhiko;
Asao, Tetsuhiko;
Takahashi, Kazuhisa;
Saeki, Sho;
Sakagami, Takuro;
Nakashima, Kazuhisa;
Tsubata, Yukari;
Fujita, Yu;
Wakui, Hiroshi;
Furuta, Megumi;
Konishi, Jun Sakakibara;
Ohuchi, Mayu

Publication type:

Article

Clinical Pharmacogenetics Implementation Consortium Guideline for CYP2B6 Genotype and Methadone Therapy.

Published in:

Clinical Pharmacology & Therapeutics, 2024, v. 116, n. 4, p. 932, doi. 10.1002/cpt.3338

By:

Robinson, Katherine M.;
Eum, Seenae;
Desta, Zeruesenay;
Tyndale, Rachel F.;
Gaedigk, Andrea;
Crist, Richard C.;
Haidar, Cyrine E.;
Myers, Alan L.;
Samer, Caroline F.;
Somogyi, Andrew A.;
Zubiaur, Pablo;
Iwuchukwu, Otito F.;
Whirl‐Carrillo, Michelle;
Klein, Teri E.;
Caudle, Kelly E.;
Donnelly, Roseann S.;
Kharasch, Evan D.

Publication type:

Article

Identification of a Safe and Tolerable Carbamazepine Dosing Paradigm that Facilitates Effective Evaluation of CYP3A4 Induction.

Published in:

Clinical Pharmacology & Therapeutics, 2024, v. 116, n. 4, p. 1034, doi. 10.1002/cpt.3332

By:

Datta‐Mannan, Amita;
Shanks, Elaine;
Yuen, Eunice;
Jin, Yan;
Rehmel, Jessica;
Hall, Stephen David

Publication type:

Article

Comprehensive Evaluation of OATP‐ and BCRP‐Mediated Drug–Drug Interactions of Methotrexate Using Physiologically‐Based Pharmacokinetic Modeling.

Published in:

Clinical Pharmacology & Therapeutics, 2024, v. 116, n. 4, p. 1013, doi. 10.1002/cpt.3329

By:

Hwang, Sejung;
Lee, Yujin;
Jang, Yeonseo;
Cho, Joo‐Youn;
Yoon, Seonghae;
Chung, Jae‐Yong

Publication type:

Article

Use of CYP2D6 Inhibitors with CYP2D6 Opioids: Association with Emergency Department Visits for Pain.

Published in:

Clinical Pharmacology & Therapeutics, 2024, v. 116, n. 4, p. 1005, doi. 10.1002/cpt.3314

By:

Nahid, Noor Ahmed;
McDonough, Caitrin W.;
Wei, Yu‐Jung Jenny;
Cicali, Emily J.;
Gong, Yan;
Fillingim, Roger B.;
Johnson, Julie A.

Publication type:

Article

Integrating Clinical Variability into PBPK Models for Virtual Bioequivalence of Single and Multiple Doses of Tofacitinib Modified‐Release Dosage Form.

Published in:

Clinical Pharmacology & Therapeutics, 2024, v. 116, n. 4, p. 996, doi. 10.1002/cpt.3313

By:

Purohit, Vivek;
Sagawa, Kazuko;
Hsu, Hao‐Jui;
Kushner, Joseph;
Dowty, Martin E.;
Tse, Susanna;
Lin, Jian;
Blanchard, Andrew;
Mukherjee, Arnab;
Le, Vu;
Chang, Cheng

Publication type:

Article

Mapping the Pharmacogenetic Landscape in a Ugandan Population: Implications for Personalized Medicine in an Underrepresented Population.

Published in:

Clinical Pharmacology & Therapeutics, 2024, v. 116, n. 4, p. 980, doi. 10.1002/cpt.3309

By:

Samarasinghe, Sumudu Rangika;
Lee, Seung‐been;
Corpas, Manuel;
Fatumo, Segun;
Guchelaar, Henk‐Jan;
Nagaraj, Shivashankar H.

Publication type:

Article

Direct Comparison of the Effectiveness and Safety Among Direct Oral Anticoagulants and Warfarin in Japanese Patients: Nationwide Cohort Study in Japan.

Published in:

Clinical Pharmacology & Therapeutics, 2024, v. 116, n. 4, p. 1023, doi. 10.1002/cpt.3331

By:

Katayama, Saki;
Aoki, Yuka;
Akita, Ayu;
Satake, Rino;
Tohkin, Masahiro

Publication type:

Article

Issue Information.

Published in:: Clinical Pharmacology & Therapeutics, 2024, v. 116, n. 4, p. 875, doi. 10.1002/cpt.2947
Publication type:: Article